NCM
Next Capital Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,503
| Closed | -$204K | – | 117 |
|
|
2022
Q2 | $204K | Buy |
3,503
+3
| +0.1% | +$175 | 0.15% | 104 |
|
|
2022
Q1 | $267K | Hold |
3,500
| – | – | 0.18% | 94 |
|
|
2021
Q4 | $211K | Buy |
+3,500
| New | +$211K | 0.14% | 99 |
|
|
2021
Q3 | – | Sell |
-3,500
| Closed | -$212K | – | 111 |
|
|
2021
Q2 | $212K | Hold |
3,500
| – | – | 0.14% | 103 |
|
|
2021
Q1 | $245K | Hold |
3,500
| – | – | 0.16% | 97 |
|
|
2020
Q4 | $209K | Buy |
+3,500
| New | +$209K | 0.15% | 99 |
|